| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.001 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.75 | 0.005 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |